Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation
Editorial Group: Cochrane Hepato-Biliary Group
Published Online: 7 JUL 2010
Assessed as up-to-date: 11 APR 2009
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Katz LH, Tur-Kaspa R, Guy DG, Paul M. Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation. Cochrane Database of Systematic Reviews 2010, Issue 7. Art. No.: CD006005. DOI: 10.1002/14651858.CD006005.pub2.
- Publication Status: New
- Published Online: 7 JUL 2010
This article has been cited by:
- 1Immunotherapies in Infectious Diseases, Medical Clinics of North America, 2012, 96, 3, 455, , , ,
- 2Polyclonal Immunoglobulins and Hyperimmune Globulins in Prevention and Management of Infectious Diseases, Infectious Disease Clinics of North America, 2011, 25, 4, 773, ,